310
Views
0
CrossRef citations to date
0
Altmetric
Articles

Presence of macroproteins on the measurement of vitamin B12: studying high vitamin B12 levels using polyethylene glycol and heterophile antibody blocking tubes

ORCID Icon & ORCID Icon
Pages 125-132 | Received 16 Nov 2022, Accepted 29 Jan 2023, Published online: 07 Feb 2023

References

  • Zeisel S. Choline, other methyl-donors and epigenetics. Nutrients. 2017;9(5):445.
  • Landgraf BJ, McCarthy EL, Booker SJ. Radical s-adenosylmethionine enzymes in human health and disease. Annu Rev Biochem. 2016;85:485–514.
  • Lanouette S, Mongeon V, Figeys D, et al. The functional diversity of protein lysine methylation. Mol Syst Biol. 2014;10(4):724.
  • Rifai N. Tietz Textbook of clinical chemistry and molecular diagnostics. 6th ed. St. Louis, MO: Elsevier, 2018.
  • Stabler SP. Clinical practice. Vitamin B12 deficiency. N Engl J Med. 2013;368(2):149–160.
  • Ermens AA, Vlasveld LT, Lindemans J. Significance of elevated cobalamin (vitamin B12) levels in blood. Clin Biochem. 2003;36(8):585–590.
  • Chaabouni K, Elleuch A, Turki M, et al. Markedly increased vitamin B12 concentration due to immunological interference. Ann Biol Clin. 2014;72(1):129–130.
  • Yang DT, Cook RJ. Spurious elevations of vitamin B12 with pernicious anemia. N Engl J Med. 2012;366(18):1742–1743.
  • Carmel R, Agrawal YP. Failures of cobalamin assays in pernicious anemia. N Engl J Med. 2012;367(4):385–386.
  • Vlasveld LT, Van’t Wout JW, Meeuwissen P, et al. High measured cobalamin (vitamin B12) concentration attributable to an analytical problem in testing serum from a patient with pernicious anemia. Clin Chem. 2006;52(1):157–158.
  • Bowen RA, Drake SK, Vanjani R, et al. Markedly increased vitamin B12 concentrations attributable to IgG-IgMvitamin B12 immune complexes. Clin Chem. 2006;52(11):2107–2114.
  • Jeffery J, Millar H, MacKenzie P, et al. An IgG complexed form of vitamin B12 is a common cause of elevated serum concentrations. Clin Biochem. 2010;43(1–2):82–88.
  • Soleimani R, Favresse J, Roy T, et al. Macro vitamin B12: an underestimated threat. Clin Chem Lab Med. 2020;58(3):408–415.
  • Wu AH. A selected history and future of immunoassay development and applications in clinical chemistry. Clin Chim Acta. 2006;369(2):119–124.
  • Sturgeon CM, Viljoen A. Analytical error and interference in immunoassay: minimizing risk. Ann Clin Biochem. 2011;48(Pt 5):418–432.
  • Kroll MH, Elin RJ. Interference with clinical laboratory analyses. Clin Chem. 1994;40(11 Pt 1):1996–2005.
  • Ghazal K, Brabant S, Prie D, et al. Hormone ımmunoassay ınterference: a 2021 update. Ann Lab Med. 2022;42(1):3–23.
  • Bolstad N, Warren DJ, Nustad K. Heterophilic antibody interference in immunometric assays. Best Pract Res Clin Endocrinol Metab. 2013;27(5):647–661.
  • Turan A. Hiperprolaktinemili hastalarda makroprolaktin ölçümünün değerlendirilmesi [Evaluation of macroprolactin measurement in patients with hyperprolactinemia] [master’s thesis]. Karadeniz Technical University, Faculty of Medicine, Department of Medical Biochemistry, Trabzon, 2011. Turkish.
  • Beda-Maluga K, Pisarek H, Komorowski J, et al. Evaluation of hyperprolactinaemia with the use of the intervals for prolactin after macroforms separation. J Physiol Pharmacol. 2014;65(3):359–364.
  • Ismail AA, Walker PL, Barth JH, et al. Wrong biochemistry results: two patient reports and observational study in 5310 patients on potentially misleading thyroid-stimulating hormone and gonadotropin immunoassay results. Clin Chem. 2002;48(11):2023–2029.
  • Deneuville T, Mario N, Tiev KP, et al. Concentration plasmatique élevée de la vitamine B12: un indicateur des maladies hépatiques ou tumorales? [High plasma concentration of vitamin B12: an indicator of hepatic diseases or tumors?]. Rev Med Interne. 2009;30(2):73. French.
  • Ismail AAA, Walker PL, Cawood ML, et al. Interference in immunoassay is an underestimated problem. Ann Clin Biochem. 2002;39(Pt 4):366–373.
  • Davis C. Introduction to immunoassay principles. In Wild D, editor. The immunoassay handbook. London: Nature Publishing Group; 2001. p. 30–31.
  • Carmel R, Vasireddy H, Aurangzeb I, et al. High serum cobalamin levels in the clinical setting-clinical associations and holo-transcobalamin changes. Clin Lab Haematol. 2001;23(6):365–371.
  • Remacha AF, Zapico E, Sarda MP, et al. Immune complexes and persistent high levels of serum vitamin B12. Int J Lab Hematol. 2014;36(1):92–97.
  • Favresse J, Bastin P, Fillée C, et al. Tracking macroprolactin: use of an optimized polyethylene glycol precipitation method more compatible with the requirements and processes of automated core laboratories. J Appl Lab Med. 2017;1(6):661–667.
  • Ismail AA. Interference from endogenous antibodies in automated immunoassays: what laboratorians need to know. J Clin Pathol. 2009;62(8):673–678.
  • Beltran L, Fahie-Wilson MN, McKenna TJ, et al. Serum total prolactin and monomeric prolactin reference intervals determined by precipitation with polyethylene glycol: evaluation and validation on common immunoassay platforms. Clin Chem. 2008;54(10):1673–1681.
  • CLSI Document C28-A3c:2008. Defining, establishing and verifying reference intervals in the clinical laboratory, approved guideline. 3rd ed. Wayne, PA: CLSI, 2008. 28: 61.
  • McLeod Donald SA, Cooper DS. The incidence and prevalence of thyroid autoimmunity. Endocrine. 2012; Oct42(2):252–265.
  • Seo HM, Kim M, Bae J, et al. A patient with painful hashimoto thyroiditis that mimicked subacute thyroiditis. Chonnam Med J. 2012;48(1):69–72.
  • Köroğlu A. Hematology primary care course training book: Otomatik kan sayım ilkeleri ve sonuçların yorumlanması [Principles of automatic blood count and interpretation of results]. İzmir: Turkish Hematology Society; 2000. Turkish.
  • Hvas AM, Nexo E. Diagnosis and treatment of vitamin B 12 deficiency. An update. Haematologica. 2006;91(11):1506–1512.
  • Merrigan SD, Yang DT, Straseski JA. Intrinsic factor blocking antibody interference is not detected in five automated cobalamin immunoassays. Am J Clin Pathol. 2014;141(5):702–705.
  • Jones AM, Honour JW. Unusual results from immunoassays and the role of the clinical endocrinologist. Clin Endocrinol. 2006;64(3):234–244.
  • Klee GG. Interferences in hormone immunoassays. Clin Lab Med. 2004;24(1):1–18.
  • Mongolu S, Armston AE, Mozley E, et al. Heterophilic antibody interference affecting multiple hormone assays: is it due to rheumatoid factor? Scand J Clin Lab Invest. 2016;76(3):240–242.
  • Kricka LJ. Human anti-animal antibody interferences in immunological assays. Clin Chem. 1999;45(7):942–956.
  • Yener S, Demir L, Demirpence M, et al. Interference in ACTH immunoassay negatively impacts the management of subclinical hypercortisolism. Endocrine. 2017;56(2):308–316.
  • Ellis MJ, Livesey JH. Techniques for identifying heterophile antibody interference are assay specific: study of seven analytes on two automated immunoassay analyzers. Clin Chem. 2005;51(3):639–641.
  • Cantor D. Reason for limitations of heterophilic blocking tube use on certain Beckman coulter access assays. Clin Chem. 2005;51(7):1311.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.